Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
155.3 USD | +1.12% | +17.10% | -14.99% |
23/04 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
23/04 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Bearish |
Resistance | 159.23 | 159.23 | 170.00 |
Spread/Res. | -3.71% | -3.71% | -9.81% |
Spread/Supp. | +18.38% | +18.38% | +18.38% |
Support | 129.52 | 129.52 | 129.52 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.